Do you need a District of Columbia Plavix lawyer? Contact one of our District of Columbia Plavix lawyers now.
Plavix - News Articles
-
May 13, 2008
Forbes, NY -
AP 05.13.08, 10:34 AM ET Bristol-Myers Squibb Co. said Tuesday it signed a deal with KAI Pharmaceuticals to develop and sell KAI's mid-stage cardiovascular ... -
May 13, 2008
Forbes, NY -
BOSTON (Thomson Financial) - Bristol-Myers Squibb Co. Tuesday said it entered its a global alliance with KAI Pharmaceuticals Inc. to develop and commercialize KAI-9803 for cardiovascular disease. KAI-9803 is KAI's isozyme-selective inhibitor of the delta ... -
May 13, 2008
Reuters -
NEW YORK (Reuters) - Bristol-Myers Squibb Co has struck a deal to develop KAI Pharmaceuticals' experimental medicine for lessening the impact of heart attacks, the companies said on Tuesday. Bristol-Myers will ... -
May 13, 2008
Bizjournals.com, NC -
Bristol-Myers Squibb Co. will pay $25 million up front to Kai Pharmaceuticals for the right to develop a heart attack drug. Kai's drug, KAI-9803, ... -
May 9, 2008
Forbes, NY -
AP 05.09.08, 3:17 PM ET US-traded shares of French drug maker Sanofi-Aventis fell Friday after a rival said it is preparing to start selling a generic version of Sanofi's anti-clotting drug Plavix. Cimex AG, a unit of Swiss generics maker Schweizerhall, said it ... -
May 9, 2008
Forbes, NY -
The blitzkrieg has begun on Sanofi-Aventis and American partner Bristol-Myers Squibb, as the patents on their blockbuster blood-thinner Plavix are being threatened in Germany. The company said it would vigorously defend the patent rights to Plavix on ... -
May 28, 2008
EasyBourse.com, France -
PARIS -(Dow Jones)- French drugmaker Sanofi-Aventis (SNY) Wednesday said it filed legal action in Germany to protect its anticlotting drug Plavix, after it became aware of the registrations of another version of the drug in Germany. Sanofi ... -
May 28, 2008
Hemscott, UK -
In a statement, Sanofi-Aventis said: 'These registrations refer to a different salt of clopidogrel than the one of Plavix, and the products are labelled only for a limited number of indications when compared to Plavix.''Sanofi-Aventis is convinced that these registrations have ... -
May 28, 2008
PharmaLive.com (press release), PA -
PARIS, May 28, 2008 – Sanofi-aventis has become aware of the registrations of Clopidogrel besylate in Germany, as reflected in the AMIS-database of the BfArM (The German Federal Drug Regulatory Authority) on May 28, 2008. document.write(' ... -
May 28, 2008
PharmaLive.com (press release), PA -
BASLE, Switzerland, May 28, 2008 --- Cimex AG received the first approval from the BfArM (Federal Institute for Drugs and Medical Devices, Germany) for the antiplatelet agent clopidogrel. Two marketing partners are expected to launch clopidogrel (original product: Plavix® / Iscover® by Bristol-Myers Squibb ...
-
May 28, 2008
TheHeart.Org, NY -
Basle, Switzerland - Cimex AG, a Swiss-based specialty generics group, has announced that it has now received approval for a generic version of clopidogrel ... -
May 28, 2008
Reuters -
ZURICH, May 28 (Reuters) - Switzerland's Schweizerhall (SWHN.S: Quote, Profile, Research) said on Wednesday its blood-thinning drug clopidogrel, a copy-cat generic version of Plavix from Sanofi-Aventis (SASY.PA: Quote , Profile , Research ) and ... -
May 28, 2008
CNNMoney.com -
ZURICH -(Dow Jones)- Swiss generics maker Schweizerhall Holding AG (SWHN.EB) said Wednesday it has received German approval for its anti-clotting drug clopidogrel, a generic version of Bristol-Myers Squibb's (BMY) Plavix and Sanofi-Aventis' (SNY) Iscover. ... -
May 28, 2008
Forbes, NY -
ZURICH (Thomson Financial) - Schweizerhall Holdings AG. said it won approval from Germany's Federal Institute for Drugs and Medical Devices to sell the blood thinning drug clopidogrel, a generic version of Sanofi-Aventis 's Plavix. ... -
May 28, 2008
Pharma Times (subscription), UK -
European regulators have revealed that Sanofi-Aventis and Bristol-Myers Squibb have withdrawn a marketing authorisation application for a drug which combines the blockbuster Plavix with aspirin. The European Medicines Agency said it had been formally notified by the ... -
May 28, 2008
Medical News Today (press release), UK -
The European Medicines Agency (EMEA) has been formally notified by Sanofi-Aventis of its decision to withdraw the application for a centralised marketing ... -
May 29, 2008
Hays Pharma, UK -
The firm submitted the application to the EMEA at this time last year but has said the decision to withdraw is based on the review of the therapeutic safety of the drug by the Committee for Medicinal Products for Human Use (CHMP). In an official letter Sanofi ... -
May 29, 2008
Pharma Times (subscription), UK -
Sanofi-Aventis is heading to the courts in a fresh bid to defend its patents on Plavix just as the Swiss firm Schweizerhall says its generic version of the blood-thinning blockbuster has been approved by German regulators. The French drugmaker issued a statement saying it has become ... -
May 27, 2008
Reuters -
By Ellis Mnyandu NEW YORK, May 27 (Reuters) - US stocks rose on Tuesday, led by technology companies such as Apple Inc (AAPL.O: Quote, Profile, Research), ... -
May 28, 2008
Reuters -
By Nick Zieminski NEW YORK, May 28 (Reuters) - US manufacturers that have developed technologies to improve customers' energy efficiency, ...
Do you need a District of Columbia Plavix lawyer? Contact one of our District of Columbia Plavix lawyers now.
Pages: 1 2 3 4 5 6 ... Next
These articles are related to: Plavix Claim, Plavix Lawsuit, Plavix Law Suit, Plavix Law Firm, Plavix Lawyer, Plavix Attorney, Plavix Side Effects Symptoms, Plavix Trial, Plavix Verdict, Plavix News, Plavix Information, Plavix Recall Lawyers, Plavix Warning, Plavix Class Action, Plavix Prescription Drug, Plavix Medication, Plavix Drugs, Clopidogrel Bisulfate Claim, Clopidogrel Bisulfate Lawsuit, Clopidogrel Bisulfate Law Suit, Clopidogrel Bisulfate Law Firm, Clopidogrel Bisulfate Lawyer, Clopidogrel Bisulfate Attorney, Clopidogrel Bisulfate Side Effects Symptoms, Clopidogrel Bisulfate Trial, Clopidogrel Bisulfate Verdict, Clopidogrel Bisulfate News, Clopidogrel Bisulfate Information, Clopidogrel Bisulfate Recall Lawyers, Clopidogrel Bisulfate Warning, Clopidogrel Bisulfate Class Action, Clopidogrel Bisulfate Prescription Drug, Clopidogrel Bisulfate Medication, Clopidogrel Bisulfate Drugs
